TVM Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications.
BiotechHealthtechMedical DevicesNew MaterialsBedford, US
James Biggins(Chief Executive Officer, President and Founder)Dennis Byrne(Chief Commercial Officer)Scott Blood(VP of Regulatory and Quality)Katie Motherway(VP of Human Resources)Paul Sabin(Director)Joseph Pellegrino(Director)
Board seatLuc Marengere· per SEC Form D
Co-investorsTVM Capital Life ScienceGreen Park & Golf Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.